SEARCH

SEARCH BY CITATION

References

  • 1
    Present DH, Korelitz BI, Wisch N, et al. Treatment of Crohn's disease with 6-mercaptopurine. A long-term randomised double-blind study. N Engl J Med 1980; 402: 9817.
  • 2
    Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn's disease. A meta-analysis. Ann Intern Med 1995; 123: 13242.
  • 3
    Present DH, Meltzer SJ, Krumholtz MP, Wolke A, Korelitz BI. 6-Mercaptopurine in the management of inflammatory bowel disease: short and long-term toxicity. Ann Intern Med 1989; 111: 6419.
  • 4
    Bouhnik Y, Lémann M, Mary J-Y, et al. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet 1996; 347: 2159.
  • 5
    Sheil AGR, Disney APS, Mathew TH, Livingston BER, Keogh AM. Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation. Transplantation Proc 1997; 29: 8257.
  • 6
    Kishikawa H, Ichikawa Y, Yazawa K, Hanafusa T, Fukunishi T, Ebisui C. Malignant neoplasm in kidney transplantation. Int J Urol 1998; 90: 5215.
  • 7
    Gaya SBM, Rees AJ, Lechler RI, Williams G, Mason PD. Malignant disease in patients with long-term renal transplants. Transplantation 1995; 59: 17059.
  • 8
    Jones M, Symmons D, Finn J, Wolfe F. Does exposure to immunosuppressive therapy increase the 10 year malignancy and mortality risks in rheumatoid arthritis? A matched cohort study. Br J Rheumatol 1996; 35: 73845.
  • 9
    Asten P, Barrett J, Symmons D. Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases. J Rheumatol 1999; 26: 170514.
  • 10
    Kinlen LJ. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med 1985; 78(Suppl.): 449.
  • 11
    Connell WR, Kamm MA, Dickson M, Balkwill AM, Ritchie JK, Lennard-Jones JE. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994; 343: 124952.
  • 12
    Korelitz BI, Mirsky FJ, Fleisher MR, Warman JI, Wisch N, Gleim GW. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine. Am J Gastroenterol 1999; 94: 324853.
    Direct Link:
  • 13
    Ekbom A. Risk factors and distinguishing features of cancer in inflammatory bowel disease. Inflamm Bowel Dis 1998; 4: 23543.
  • 14
    Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer; a population-based study. N Engl J Med 1990; 323: 122833.
  • 15
    Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. IV. Carcinoma of the colon. Gut 1964; 5: 1522.
  • 16
    Gyde SN, Prior P, Allan RN, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 1988; 29: 20617.
  • 17
    Gillen CD, Walmsley RS, Prior P, et al. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994; 35: 15902.
  • 18
    Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large bowel cancer in Crohn's disease with colonic involvement. Lancet 1990; 336: 3579.
  • 19
    Goldstein ES, Marion JF, Wheeler S, Present DH. 6-mercaptopurine: does it increase or decrease the risk of colon cancer in Crohn's disease. Gastroenterology 1998; 114: A986 (Abstract).
  • 20
    Lewis JD, Billker WB, Brensinger C, Deren JJ, Vaughn DJ, Strom BL. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 2001; 121: 123942.
  • 21
    Masel SL, Hanauer SB. Increased association of lymphoma and inflammatory bowel disease. Gastroenterology 2000; 118(Suppl. 2): A119(Abstract).
  • 22
    Palli D, Trallori G, Bagnoli S, et al. Hodgkin's disease risk is increased in patients with ulcerative colitis. Gastroenterology 2000; 119: 64753.
  • 23
    Farrell RJ, Ang Y, Kileen P, et al. Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut 2000; 47: 5149.
  • 24
    Dayharsh GA, Loftus EV, Sandborn WJ, et al. Epstein–Barr virus positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. Gastroenterology 2002; 122: 727.